
Dutaxel 30mg Injection
Marketer
Samarth Life Sciences Pvt Ltd
Salt Composition
Paclitaxel (30mg)
Overview Dutaxel 30mg Injection
Oncaspar (30mg injectable) is a chemotherapy agent indicated for treating breast, pancreatic, and non-small cell lung cancers. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician based on your condition and may vary. Strict adherence to the prescribed regimen is crucial; improper usage or overdose can lead to severe adverse reactions. Therapeutic benefits may not be apparent for weeks or months; discontinue only under medical supervision. Typical side effects include nausea, vomiting, and fatigue; serious side effects such as edema (hand and lip swelling), alopecia, and weight increase are also possible. Concomitant medications may mitigate some side effects. Report any unusual bruising or bleeding, pharyngitis, oral ulcers, or fever immediately. This medication can suppress blood cell counts (red and white blood cells), increasing infection risk. Regular blood work, including liver function tests, is mandatory. Prior to initiating treatment, disclose any pre-existing heart, liver, or kidney conditions, and all medications, including antibiotics. Numerous drug interactions are possible; full disclosure of all medications is essential. This drug is contraindicated during pregnancy and lactation; reliable contraception is vital for both partners during therapy.
Uses of Dutaxel 30mg Injection
Cancers of the breast, lung (non-small cell type), and pancreas.
Major Benefits of Dutaxel 30mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Dutaxel 30mg Injection:
- Nausea
- Vomiting
- Weakness
- Low blood platelets
- Rash
- Upper respiratory tract infection
- Urinary tract infection
- Bleeding
- Anemia (low number of red blood cells)
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Hair loss
- Decreased blood pressure
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Diarrhea
- Decreased white blood cell count (neutrophils)
How to use Dutaxel 30mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Dutaxel 30mg Injection works:
Oncaspar 30mg injection is a cancer treatment that disrupts the microtubule networks crucial for cancer cell division and proliferation, thus inhibiting tumor growth and leading to cell death.
SAFETY ADVICE
AlcoholUNSAFE
Combining Dutaxel 30mg Injection and alcohol is strongly discouraged due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Administering Dutaxel 30mg Injection to pregnant individuals poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional circumstances involving a life-threatening condition, a physician might deem the potential benefits outweigh the risks, necessitating careful consideration. Physician consultation is mandatory.
Breast feedingUNSAFE
Administering Dutaxel 30mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Driving ability may be impaired by Dutaxel 30mg Injection side effects. While there's no inherent prohibition on driving between treatment cycles, the injection's alcohol content warrants caution regarding driving.
KidneySAFE IF PRESCRIBED
Patients with kidney disease can safely receive Dutaxel 30mg Injection without a recommended dosage change. Nevertheless, consult your physician regarding any pre-existing kidney conditions.
LiverCAUTION
Patients with liver impairment should receive 30mg Dutaxel injections cautiously, potentially requiring dosage modification. Consult a physician. The administration of 30mg Dutaxel injections is contraindicated in those with severe hepatic dysfunction.
What if you forget to take Dutaxel 30mg Injection :
NA
Facts to Know About Dutaxel 30mg Injection
| Label | Value |
|---|---|
| Chemical Type | Taxane Derivatives |
| Developing Habits | No. |
| Type of Therapy | Cancer Medications |
| Behavior Class | Taxanes: Antimicrotubule Agents |
